GREG PYSZCZYMUKA
CIK 1952920 · Chief Commercial Officer · last filed 2025-12-17
GREG PYSZCZYMUKA is a Chief Commercial Officer who has filed 17 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for EVOK, was dated Dec 17, 2025. Across all open-market trades the lifetime net is +$46.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $77.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$77.6K
2
17
$46.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc (EVOK) Delisted | Director | — | $11.00 | — | $0 | 3 | 2025-12-17 |
| AYTU | Chief Commercial Officer | 36,102 | $2.15 | $77.6K | $46.9K | 14 | 2025-10-07 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-17 | Evoke Pharma Inc (EVOK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-10-07 | AYTU | Grant (A) | +12,500 | $0 | EDGAR |
| 2025-05-22 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-31 | AYTU | Exer (M) | +209 | $0 | EDGAR |
| 2025-02-24 | Evoke Pharma Inc (EVOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | AYTU | Exer (M) | +208 | $0 | EDGAR |
| 2024-11-08 | AYTU | Grant (A) | — | $0 | EDGAR |
| 2024-10-02 | AYTU | Exer (M) | +209 | $0 | EDGAR |
| 2024-07-02 | AYTU | Exer (M) | +208 | $0 | EDGAR |
| 2024-04-02 | AYTU | Exer (M) | +208 | $0 | EDGAR |